SCHEMBL2184283

SCHEMBL2184283

COC(=O)C(C)c1ccc2c(c1)c1ccccc1n2C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.52
▸ MT-CO2 P00403 1/20 0.52
▸ HPGD P15428 6/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ MAPT P10636 4/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ PTGS2 P35354 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ PTGS1 P23219 1/20 0.49
▸ PSEN1 P49768 1/20 0.48
▸ PSEN2 P49810 1/20 0.48
▸ APH1B Q8WW43 1/20 0.48
▸ NCSTN Q92542 1/20 0.48
▸ APH1A Q96BI3 1/20 0.48
▸ PSENEN Q9NZ42 1/20 0.48
▸ NPY5R Q15761 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2184668 0.84 KDM4E (0.60) KDM4EHPGDALDH1A1MAPTKMT2A
SCHEMBL1102397 0.78 GPR3 (0.59) KDM4EHPGDALDH1A1MAPTKMT2A
SCHEMBL22070145 0.77 KDM4E (0.46) KDM4EHPGDALDH1A1MAPTKMT2A
SCHEMBL21374983 0.74 GPR3 (0.53) KDM4EHPGDALDH1A1MAPTKMT2A
SCHEMBL12083593 0.73 GPR3 (0.52) KDM4EHPGDALDH1A1MAPTKMT2A
SCHEMBL9760859 0.72 KDM4E (0.69) KDM4EHPGDALDH1A1MAPTKMT2A
SCHEMBL2183508 0.71 HPGD (0.84) KDM4EHPGDALDH1A1MAPTKMT2A
SCHEMBL8189543 0.71 KIF11 (0.60) MT-CO2MAPTKMT2AMEN1PTGS2
SCHEMBL4728744 0.71 MAPT (0.74) KDM4EHPGDALDH1A1MAPTKMT2A
SCHEMBL18412610 0.71 MAOA (0.55) KDM4EMT-CO2HPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166132-A1 Gamma Secretase Modulators AMGEN INC. (US) 2011-07-07 — — US disclosed
EP-2231602-A1 GAMMA SECRETASE MODULATORS Amgen, Inc (US) 2010-09-29 — — EP disclosed
WO-2009075874-A1 GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-06-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166132-A1 Gamma Secretase Modulators BACE1, BACE2, PSEN1 KDM4E 2860/4885MT-CO2 3879/4885HPGD 1916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback